Your browser doesn't support javascript.
loading
Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab.
Yamaguchi, Ou; Kaira, Kyoichi; Hashimoto, Kosuke; Mouri, Atsuto; Miura, Yu; Shiono, Ayako; Nishihara, Fuyumi; Murayama, Yoshitake; Noda, Shin-Ei; Kato, Shingo; Kobayashi, Kunihiko; Kagamu, Hiroshi.
Afiliación
  • Yamaguchi O; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Kaira K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Hashimoto K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Mouri A; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Miura Y; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Shiono A; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Nishihara F; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Murayama Y; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Noda SE; Department of Radiation Oncology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Kato S; Department of Radiation Oncology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Kobayashi K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Kagamu H; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
Thorac Cancer ; 10(4): 992-1000, 2019 04.
Article en En | MEDLINE | ID: mdl-30888716
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Nivolumab / Neoplasias Pulmonares / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Thorac Cancer Año: 2019 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Nivolumab / Neoplasias Pulmonares / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Thorac Cancer Año: 2019 Tipo del documento: Article País de afiliación: Japón